281 related articles for article (PubMed ID: 22374979)
1. Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.
Fowler JA; Mundy GR; Lwin ST; Edwards CM
Cancer Res; 2012 May; 72(9):2183-9. PubMed ID: 22374979
[TBL] [Abstract][Full Text] [Related]
2. Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment.
Giuliani N; Morandi F; Tagliaferri S; Lazzaretti M; Donofrio G; Bonomini S; Sala R; Mangoni M; Rizzoli V
Cancer Res; 2007 Aug; 67(16):7665-74. PubMed ID: 17702698
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow stromal cells from myeloma patients support the growth of myeloma stem cells.
Feng Y; Wen J; Mike P; Choi DS; Eshoa C; Shi ZZ; Zu Y; Chang CC
Stem Cells Dev; 2010 Sep; 19(9):1289-96. PubMed ID: 20121456
[TBL] [Abstract][Full Text] [Related]
4. Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease.
D'Souza S; del Prete D; Jin S; Sun Q; Huston AJ; Kostov FE; Sammut B; Hong CS; Anderson JL; Patrene KD; Yu S; Velu CS; Xiao G; Grimes HL; Roodman GD; Galson DL
Blood; 2011 Dec; 118(26):6871-80. PubMed ID: 22042697
[TBL] [Abstract][Full Text] [Related]
5. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
[TBL] [Abstract][Full Text] [Related]
6. Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation.
Xu G; Liu K; Anderson J; Patrene K; Lentzsch S; Roodman GD; Ouyang H
Blood; 2012 May; 119(18):4205-14. PubMed ID: 22427205
[TBL] [Abstract][Full Text] [Related]
7. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma.
Gunn WG; Conley A; Deininger L; Olson SD; Prockop DJ; Gregory CA
Stem Cells; 2006 Apr; 24(4):986-91. PubMed ID: 16293576
[TBL] [Abstract][Full Text] [Related]
8. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells.
Wang J; Hendrix A; Hernot S; Lemaire M; De Bruyne E; Van Valckenborgh E; Lahoutte T; De Wever O; Vanderkerken K; Menu E
Blood; 2014 Jul; 124(4):555-66. PubMed ID: 24928860
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.
Heath DJ; Chantry AD; Buckle CH; Coulton L; Shaughnessy JD; Evans HR; Snowden JA; Stover DR; Vanderkerken K; Croucher PI
J Bone Miner Res; 2009 Mar; 24(3):425-36. PubMed ID: 19016584
[TBL] [Abstract][Full Text] [Related]
11. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.
Tian E; Zhan F; Walker R; Rasmussen E; Ma Y; Barlogie B; Shaughnessy JD
N Engl J Med; 2003 Dec; 349(26):2483-94. PubMed ID: 14695408
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional silencing of the Wnt-antagonist DKK1 by promoter methylation is associated with enhanced Wnt signaling in advanced multiple myeloma.
Kocemba KA; Groen RW; van Andel H; Kersten MJ; Mahtouk K; Spaargaren M; Pals ST
PLoS One; 2012; 7(2):e30359. PubMed ID: 22363428
[TBL] [Abstract][Full Text] [Related]
13. A comparison of cytokine production in 2-dimensional and 3-dimensional cultures of bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells.
Zdzisińska B; Roliński J; Piersiak T; Kandefer-Szerszeń M
Folia Histochem Cytobiol; 2009; 47(1):69-74. PubMed ID: 19419941
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-kappaB activity in myeloma cells.
Markovina S; Callander NS; O'Connor SL; Xu G; Shi Y; Leith CP; Kim K; Trivedi P; Kim J; Hematti P; Miyamoto S
Mol Cancer; 2010 Jul; 9():176. PubMed ID: 20604947
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.
Nefedova Y; Landowski TH; Dalton WS
Leukemia; 2003 Jun; 17(6):1175-82. PubMed ID: 12764386
[TBL] [Abstract][Full Text] [Related]
16. Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone.
Trotter TN; Gibson JT; Sherpa TL; Gowda PS; Peker D; Yang Y
Am J Pathol; 2016 Nov; 186(11):3054-3063. PubMed ID: 27648615
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of APE1/Ref-1 and its regulation on IL-6 and IL-8 in bone marrow stromal cells of multiple myeloma.
Xie JY; Li MX; Xiang DB; Mou JH; Qing Y; Zeng LL; Yang ZZ; Guan W; Wang D
Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):385-93. PubMed ID: 21030352
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the receptor activator of NF-kappaB ligand and osteoprotegerin production influence the apoptosis of multiple myeloma patients' bone marrow stromal cells co-cultured with myeloma cells.
Zdzisińska B; Bojarska-Junak A; Walter-Croneck A; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):153-63. PubMed ID: 20157786
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation.
Guo J; Liu M; Yang D; Bouxsein ML; Saito H; Galvin RJ; Kuhstoss SA; Thomas CC; Schipani E; Baron R; Bringhurst FR; Kronenberg HM
Cell Metab; 2010 Feb; 11(2):161-71. PubMed ID: 20142103
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes.
Binder M; Szalat RE; Talluri S; Fulciniti M; Avet-Loiseau H; Parmigiani G; Samur MK; Munshi NC
Nat Commun; 2024 May; 15(1):4139. PubMed ID: 38755155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
